Jump to content

Synthetic Biology

Synthetic Biology is a dynamic field of research with an application-related focus to which contributions are made from disciplines that have a biological, technical and information processing emphasis. The main research fields and goals of Synthetic Biology have already been introduced by the German Central Committee on Biological Safety (ZKBS) (key word Synthetic Biology in the focus topics section).

Figure 1 shows important events in the fields of Synthetic Biology together with milestones in basic research that made them possible.

The Federal Ministry of Food and Agriculture (BMEL) has commissioned the ZKBS to monitor developments in the field of Synthetic Biology in order to expertly and with a view to biosafety monitor current scientific developments in various fields of research. The monitoring aims to identify in good time whether existing regulations need to be adapted.

There is no specific regulation in Germany or Europe for risk assessment in Synthetic Biology. Because most research approaches in Synthetic Biology generate genetically modified organisms (GMOs), their potential risk can be assessed using existing methods. These can be found in the European Directives 2009/41/EC (System Directive, contained use) and 2001/18/EC (Deliberate Release Directive), which have been implemented in the German Genetic Engineering Act (GenTG). The ZKBS checks whether the current research projects are covered through the applicability of the GenTG.

The ZKBS published its first report on Synthetic Biology (not accessible) [PDF, 91KB] in Germany in 2012. The second ZKBS report (not accessible) [PDF, 1.22MB] appeared in 2018, summarizing the state of research in the various fields of Synthetic Biology worldwide.

The ZKBS has been conducting continuous monitoring of developments in the field of Synthetic Biology since June 2018. A selection of relevant publications is presented here and is updated regularly. Based on the continuous monitoring, the third report on synthetic biology (not accessible) [PDF, 672KB] was published in July 2022.

All three ZKBS reports (status December 2021) establish that all of the research areas in Synthetic Biology defined by the ZKBS are regulated by already existing legal specifications such as European directives and the GenTG and currently there is no need for action in this regard.

Individual subfields of synthetic cell research, for example research on bacterial cell division systems, take place in vitro, that is outside of living systems, and are not encompassed by the GenTG. These studies to date include no recognizable specific hazard potential; these systems involve no organisms capable of life.

References for the timeline of Synthetic Biology

1 Avery et al., 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a desoxyriboenucleic acid fraction isolated from pneumococcus type III. J Exp Med 79 (2):137–58.

2 Chang & Cohen, 1974. Genome Construction Between Bacterial Species In Vitro: Replication and Expression of Staphylococcus Plasmid Genes in Escherichia coli. Proc Natl Acad Sci U S A 71(4):1030-4.

3 Sanger et al., 1977. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74(12):5463-7.

4 Khorana et al., 1979. Total Synthesis of a Gene. Science 203(4381):614-25.

5 Review: Dai & Chen, 2022. Advances and Trends in Omics Technology Development. Front Med (Lausanne). 1(9): 911861.

6 https://www.ncbi.nlm.nih.gov/genbank/

Benson et al., 1993. GenBank. Nucleic Acids Res. 21(13):2963-5.

7 Bevan et al., 1983. A chimaeric antibiotic resistance gene as a selectable marker for plant cell transformation. Nature 304:184-7.

8 Patent US4683202A : Process for amplifying nucleic acid sequences. Filed Oct. 25, 1985; Date of Patent: Jul.28, 1987; Assignee: Cetus Corp, Inventor: Kary B. Mullis

Mullis et al., 1986. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol. 51 Pt 1:263-73.

9 Altschul et al., 1990. Basic local alignment search tool. J Mol Biol 215(3):403-10.

10 Fleischmann et al., 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269(5223):496-512.

Blattner et al., 1997. The complete genome sequence of Escherichia coli K-12. Science. 277(5331):1453-62.

Goffeau et al., 1996. Life with 6000 genes. Science 274(5287):546, 563-7.

11 The Arabidopsis Genome Initiative, 2000. Analysis of the genome sequence of the flowering plant Arabidopsis thaliana. Nature 408:796–815.

Eckardt , 2000. Sequencing the rice genome. Plant Cell 12(11):2011-7.

12 Elowitz & Leibler, 2000. A synthetic oscillatory network of transcriptional regulators. Nature 403(6767):335-8.

Review: MacDonald & Daens, 2016. Tools and applications in Synthetic Biology. Adv Drug Deliv Rev 105(Pt A):20-34.

13 Mouse Genome Sequencing Consortium, 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420:520–62.

14 Cello et al., 2002. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 297(5583):1016-8.

15 International Human Genome Sequencing Consortium, 2004. Finishing the euchromatic sequence of the human genome. Nature 431(7011):931-45.

16 Martin et al., 2003. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol. 21(7):796-802.

17 Anderson et al., 2006. Environmentally controlled invasion of cancer cells by engineered bacteria. J Mol Biol. 355(4):619–27.

Review: Chien et al., 2017. Advances in Bacteria Cancer Therapies using Synthetic Biology. Curr Opin Syst Biol 5:1-8.

18 Kalscheuer et al., 2006. Escherichia coli engineered for fuel production. Microbiology (Reading). 2006 Sep;152(Pt 9):2529-36.

Review: Clomburg at al., 2010. Biofuel production in Escherichia coli: the role of metabolic engineering and synthetic biology. Appl Microbiol Biotechnol 86(2):419–34.

19 Eid et al., 2009. Real-time DNA sequencing from single polymerase molecules. Science 323(5910):133-8.

Clarke et al., 2009. Continuous base identification for single-molecule nanopore DNA sequencing. Nat Nanotechnol. 4(4):265-70.

20 Gibson et al., 2010. Creation of a bacterial cell controlled by a chemically synthesized genome. Science 329(5987):52-6.

21 Kim et al., 1996. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA 93(3):1156–60.

Christian et al., 2010. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics. 186(2):757-61.

Jinek et al., 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 337(6096):816-21.

22 Annaluru et al., 2014. Total synthesis of a functional designer eukaryotic chromosome. Science 344(6179):55-8.

23 Caschera & Noireaux, 2014. Integration of biological parts toward the synthesis of a minimal cell. Curr Opin Chem Biol 22:85-91.

24 Galanie et al., 2015. Complete biosynthesis of opioids in yeast. Science 349(6252):1095-100.

25 Ostrov et al., 2016. Design, synthesis, and testing toward a 57-codon genome. Science 353(6301):819-22.

26 Schwander et al., 2016. A synthetic pathway for the fixation of carbon dioxide in vitro. Science 354(6314):900-4.

27 Hutchison et al., 2016. Design and synthesis of a minimal bacterial genome. Science 351(6280):aad6253.

28 Acevedo -Rocha & Budisa, 2016. Xenomicrobiology: a roadmap for genetic code engineering. Microb Biotechnol 9(5):666-76.

29 Richardson et al., 2017. Design of a synthetic yeast genome. Science 355(6329):1040-44.

30 Shipman et al., 2017. CRISPR-Cas encoding of a digital movie into the genomes of a population of living bacteria. Nature 547(7663):345-9.

31 Noyce et al., 2018. Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments. PLoS ONE 13(1): e0188453.

32 Gleizer et al., 2019. Conversion of Escherichia coli to Generate All Biomass Carbon from CO2. Cell 179(6):1255-63.e12.

33 Fredens et al., 2019. Total synthesis of Escherichia coli with a recoded genome. Nature 569(7757):514.8.

34 Kriegman et al., 2020. A scalable pipeline for designing reconfigurable organisms. Proc Natl Acad Sci U S A 117(4):1853-9.

35 Mansouri et al., 2021. Smartphone-Flashlight-Mediated Remote Control of Rapid Insulin Secretion Restores Glucose Homeostasis in Experimental Type-1 Diabetes. Small 17(35): e2101939.

36 Luo et al.,2023. ATP production from electricity with a new-tonature electrobiological module. Joule 7(8): 1745-58.

37 Chen et al., 2024. A designer synthetic chromosome fragment functions in moss. Nat Plants 10(2):228-39.